These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26034621)
1. Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced delivery. Oberg JA; Dave AN; Bruce JN; Sands SA Neurooncol Pract; 2014 Sep; 1(3):94-100. PubMed ID: 26034621 [TBL] [Abstract][Full Text] [Related]
2. Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma. Surapaneni K; Kennedy BC; Yanagihara TK; DeLaPaz R; Bruce JN World Neurosurg; 2015 Jul; 84(1):163-72. PubMed ID: 25772608 [TBL] [Abstract][Full Text] [Related]
3. Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Bruce JN; Fine RL; Canoll P; Yun J; Kennedy BC; Rosenfeld SS; Sands SA; Surapaneni K; Lai R; Yanes CL; Bagiella E; DeLaPaz RL Neurosurgery; 2011 Dec; 69(6):1272-9; discussion 1279-80. PubMed ID: 21562434 [TBL] [Abstract][Full Text] [Related]
5. Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience. Upadhyayula PS; Spinazzi EF; Argenziano MG; Canoll P; Bruce JN Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33396668 [TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
7. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials. Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M; Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200 [TBL] [Abstract][Full Text] [Related]
8. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Li J; Bentzen SM; Li J; Renschler M; Mehta MP Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884 [TBL] [Abstract][Full Text] [Related]
9. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study. van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314 [TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285 [TBL] [Abstract][Full Text] [Related]
11. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Wefel JS; Noll KR; Rao G; Cahill DP Neuro Oncol; 2016 Dec; 18(12):1656-1663. PubMed ID: 27576872 [TBL] [Abstract][Full Text] [Related]
12. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. Lidar Z; Mardor Y; Jonas T; Pfeffer R; Faibel M; Nass D; Hadani M; Ram Z J Neurosurg; 2004 Mar; 100(3):472-9. PubMed ID: 15035283 [TBL] [Abstract][Full Text] [Related]
13. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note. Tanner PG; Holtmannspötter M; Tonn JC; Goldbrunner R Neurosurgery; 2007 Oct; 61(4):E880-2; discussion E882. PubMed ID: 17986926 [TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695 [TBL] [Abstract][Full Text] [Related]
15. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586 [TBL] [Abstract][Full Text] [Related]
16. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230 [TBL] [Abstract][Full Text] [Related]
17. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models. Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269 [TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109 [TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery in the treatment of malignant glioma. Lopez KA; Waziri AE; Canoll PD; Bruce JN Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887 [TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. Monk BJ; Huang HQ; Cella D; Long HJ; J Clin Oncol; 2005 Jul; 23(21):4617-25. PubMed ID: 15911864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]